BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 28741603)

  • 1. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    Wang L; Hao K; Yang T; Wang C
    Chin Med J (Engl); 2017 Sep; 130(17):2107-2111. PubMed ID: 28741603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
    Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
    Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ; Boushey HA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?
    Sethi S
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S43-7. PubMed ID: 24437405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lung microbiome and exacerbations of COPD.
    Dy R; Sethi S
    Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease.
    Sze MA; Dimitriu PA; Suzuki M; McDonough JE; Campbell JD; Brothers JF; Erb-Downward JR; Huffnagle GB; Hayashi S; Elliott WM; Cooper J; Sin DD; Lenburg ME; Spira A; Mohn WW; Hogg JC
    Am J Respir Crit Care Med; 2015 Aug; 192(4):438-45. PubMed ID: 25945594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease.
    Liu J; Ran Z; Wang F; Xin C; Xiong B; Song Z
    Crit Rev Microbiol; 2021 Feb; 47(1):1-12. PubMed ID: 33040638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung microbiome mediates the progression from chronic obstructive pulmonary disease to lung cancer through inflammation.
    Wang YJ; Wu SS; Chu J; Kong XY
    Yi Chuan; 2021 Jan; 43(1):30-39. PubMed ID: 33509772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD and the microbiome.
    Mammen MJ; Sethi S
    Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives.
    Dima E; Kyriakoudi A; Kaponi M; Vasileiadis I; Stamou P; Koutsoukou A; Koulouris NG; Rovina N
    Respir Med; 2019 Oct; 157():1-6. PubMed ID: 31450162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
    Lee SW; Kuan CS; Wu LS; Weng JT
    PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of infection in exacerbations of chronic obstructive pulmonary disease.
    Miravitlles M; Anzueto A
    Curr Opin Pulm Med; 2015 May; 21(3):278-83. PubMed ID: 25719955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens.
    Santoro A; Tomino C; Prinzi G; Cardaci V; Fini M; Macera L; Russo P; Maggi F
    Curr Med Chem; 2020; 27(18):2931-2948. PubMed ID: 31838985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
    Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
    Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.
    Cabrera-Rubio R; Garcia-Núñez M; Setó L; Antó JM; Moya A; Monsó E; Mira A
    J Clin Microbiol; 2012 Nov; 50(11):3562-8. PubMed ID: 22915614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The microbiome in chronic obstructive pulmonary disease].
    Diao Wenqi WQ; Xu Ming M; He Bei B
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):982-985. PubMed ID: 30522199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.